Guardant Health, Inc.
GH
$35.84
-$3.48-8.85%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 31.04% | 29.20% | 26.20% | 25.21% | 25.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.04% | 29.20% | 26.20% | 25.21% | 25.45% |
| Cost of Revenue | 27.64% | 29.80% | 32.54% | 34.87% | 45.24% |
| Gross Profit | 33.34% | 28.82% | 22.29% | 19.60% | 14.90% |
| SG&A Expenses | 20.96% | 10.41% | -2.28% | -5.35% | -3.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.18% | 6.98% | 1.51% | 1.16% | 5.50% |
| Operating Income | 7.76% | 16.16% | 21.58% | 19.69% | 11.08% |
| Income Before Tax | 9.12% | -19.02% | 3.26% | 30.66% | 26.73% |
| Income Tax Expenses | 87.45% | -98.52% | -66.48% | -39.42% | -39.86% |
| Earnings from Continuing Operations | 8.98% | -18.52% | 3.44% | 30.68% | 26.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.98% | -18.52% | 3.44% | 30.68% | 26.76% |
| EBIT | 7.76% | 16.16% | 21.58% | 19.69% | 11.08% |
| EBITDA | 8.40% | 17.74% | 23.79% | 21.98% | 13.24% |
| EPS Basic | 16.91% | -4.21% | 16.79% | 39.62% | 33.21% |
| Normalized Basic EPS | 14.51% | 27.14% | 34.61% | 45.94% | 35.49% |
| EPS Diluted | 16.91% | -4.21% | 16.79% | 39.62% | 33.21% |
| Normalized Diluted EPS | 14.51% | 27.14% | 34.61% | 45.94% | 35.49% |
| Average Basic Shares Outstanding | 9.66% | 12.51% | 15.40% | 13.98% | 9.54% |
| Average Diluted Shares Outstanding | 9.66% | 12.51% | 15.40% | 13.98% | 9.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
